Vol. 29 No. 4 (2019): Revista Ciência Animal
Artigos Originais

Evaluation of c-kit protein (CD-117) immunostaining in canine mammary tumors

André Rebelo PANTOJA
Universidade da Amazônia (UNAMA)
Marina Mariana de Sousa BASTOS
Hospital Veterinário da Universidade Federal Rural da Amazônia (UFRA)
Carolina Franchi JOÃO
Universidade Federal do Pará (UFPA)
Mário José Costa CARNEIRO
Universidade Federal do Pará (UFPA)
Pedro Silva BEZERRA
Universidade Federal do Pará (UFPA)

Published 2019-12-31

Keywords

  • Mammary tumor,
  • CD117,
  • immunohistochemistry,
  • female dogs

How to Cite

Evaluation of c-kit protein (CD-117) immunostaining in canine mammary tumors. Ciência Animal, [S. l.], v. 29, n. 4, p. 32–38, 2019. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/9728. Acesso em: 26 apr. 2026.

Abstract

Mammary neoplasms in dogs have a significant relevance in the veterinary clinical routine and the search for new associated factors in its etiopathogenesis and therapy is necessary to enable the study of new more effective therapies. This study aimed to evaluate the behavior of c-kit expression in benign and malignant canine mammary tumors by immunohistochemistry. The samples were evaluated for intensity staining, percentage of labeled cells, to obtain the final score. For the positive control was used a positive mastocytoma sample for c-kit expression. 32 samples of breast carcinomas and five samples of benign breast tumors were used. All tumors express c-kit, with cytoplasmic pattern. Sixteen carcinomas showed a low score of immunostaining and 16 had high scores. All benign breast tumors had high immunostaining score. Expression of c-kit was greater in tumors compared to benign malignant tumors. The anaplastic carcinomas showed high final score and grade III. suggesting greater expression in this tumor type.

References

  1. AL-DISSI, A.N.; HAINES, D.M.; SINGH, B.; KIDNEY, B.A. Immunohistochemical
  2. expression of vascular endothelial growth factor and vascular endothelial growth factor
  3. receptor-2 in canine simple mammary gland adenocarcinomas. The Canadian Veterinary
  4. Journal, v.5, n.10, 2010.
  5. CASSALI, G.D.; LAVALLE, G.E.; DE NARDI, A.B.; FERREIRA, E.; BERTAGNOLLI,
  6. A.C.; ESTRELA-LIMA, A.; ALESSI, A.C.; DALECK, C.R.; SALGADO, B.S.;
  7. FERNANDES, C.G.; SOBRAL, R.A.; AMORIM, R.L.; GAMBA, C.O.; DAMASCENO,
  8. K.A.; AULER, P.A.; MAGALHÃES, G.M.; SILVA, J.O.; RAPOSO, J.J.; FERREIRA,
  9. A.M.R.; OLIVEIRA, L.O.; MALM, C.; ZUCCARI, D.A.P.C.; TANAKA, N.M.; RIBEIRO,
  10. L.R.; CAMPOS, L.C.; SOUZA, C.M.; LEITE, J.S.; SOARES, L.M.C.; CAVALCANTI,
  11. M.F.; FONTELES, Z.G.C.; SCHUCH, I.D.; PANIAGO, J.; OLIVEIRA, T.S.; TERRA,
  12. E.M.; CASTANHEIRA, T.L.L.; FELIX, A.O.C.; CARVALHO, G.D.; GUIM, T.N.; GUIM,
  13. T.N.; GARRIDO, E.; FERNANDES, S.C.; MAIA, F.C.L.; DAGLI, M.L.Z.; ROCHA, N.S.;
  14. FUKUMASU, H.; GRANDI, F.; MACHADO, J.P.; SILVA, S.M.M.S.; BEZERRI, J.E.;
  15. FREHSE, M.S.; PAES DE ALMEIDA, E.C.; CAMPUS, C.B. Consensus for the diagnosis,
  16. prognosis and treatment of canine mammary tumors. Brazilian Journal of Veterinary
  17. Pathology, v.4, p.153-180, 2014.
  18. INCA (Instituto Nacional do Câncer). Tipos de câncer: mama. Rio de Janeiro: Ministério da
  19. Saúde; 2013. Acesso em 19 de maio de 2015. Disponível em:
  20. http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/mama>. Acesso em 13
  21. de abril de 2016.
  22. KARAYANNOPOULOU, M.; KALDRYMIDOU, E.D.A. Histological grading and
  23. prognosis in dogs with mammary Carcinomas: application of a human grading method.
  24. Journal of Comparative Pathology, v.133, p.246-252, 2005.
  25. LAVALLE, G.E.; BERTAGNOLLI, A.C.; TAVARES, W.L.F.; CASSALI, G.D. COX-2
  26. Expression in Canine Mammary Carcinomas: Correlation with Angiogenesis and Overall
  27. Survival. Veterinary Pathology, v.46, p.1275-1280, 2009.
  28. LONDON, C.A. Tyrosine kinase inhibitors in veterinary medicine. Topic in Companion
  29. Animal Medicine, v.24, p.106-112, 2009.
  30. MARTINI, A.R.A.F.; DAMIANO, R.F.; TOLEDO, M.T.; SANTOS, N.B.;
  31. RODRIGUEIRO, D.A. Expressão de c-kit como fator prognóstico para pacientes com
  32. câncer de mama triplo-negativos. Revista da Faculdade de Ciências Médicas de Sorocaba,
  33. v.16, 2014.
  34. MAFFINI, M.V.; SOTO A.M.; SONNENSCHEIN, C.; PAPADOPOULOS, N.;
  35. THEOHARIDES, T.C. Lackof c-kit receptor promotesmammarytumors in Nnitrosomethylurea-
  36. treated Ws/Ws rats. Cancer Cell International, v.8, p.5, 2008.
  37. MISDORP W.; ELSE R.W.H. Histological classification of mammary tumors of the dog
  38. and the cat. 2a ed., Washington: Armed Forces Institute of Pathology, v.7, n.59, p.18-27,
  39. MUNDIM, F.G.L.; LOGULLO, A.F. Role of the expression of the tyrosine kinase receptor
  40. KIT in invasive ductal carcinomas of the breast. Applied Cancer Research, v.29, n.2, p.50-
  41. , 2009.
  42. POLAT, A. C-kit expression in columnar cell lesions of the breast ac- companied by benign
  43. and malignant breast diseases. Pathology, Research and Practice, v.203, p.765-9, 2007.
  44. REGUERA, M.J.; RABANAL, R.M.; PUIGDEMONT, A.; FERRER, L. Canine mast cell
  45. tumors express stem cell factor receptor. American Journal of Dermathopatology, v.22, p.49-
  46. , 2000.
  47. SALVADOR, R.C.L. Expressão gênica e proteica da cox-2 e c-kit em neoplasias mamárias
  48. de cadelas. 79p. Dissertação apresentada à Faculdade de Ciências Agrárias e Veterinárias –
  49. UNESP, Campus de Jaboticabal, 2014.